Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Nishant Shah

Preventive Cardiology · Duke Hospital

View

Dr. Amit Khera

Preventive Cardiology · UT Southwestern

View

Dr. Martha Gulati

Preventive Cardiology · Houston Methodist

View

Dr. Pradeep Natarajan

Preventive Cardiology · MGH

View

Dr. Christopher Cannon

Preventive Cardiology · BWH

View

Dr. Nicholas Marston

Preventive Cardiology · BWH

View

Dr. Dorairaj Prabhakaran

General Cardiology

View

Dr. Pugazhendhi Vijayaraman

EP · Geisinger

View

Dr. Robert Schaller

EP · HUP

View

Dr. Trey Woods

General Cardiology · Emory Healthcare

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    MSDr. Michael Shapiro

    Dr. Michael Shapiro

    Cardiology · Preventive Cardiology
    Wake Forest University Health Sciences
    michaels

    Research

    Disparities in statin use following identification of coronary artery calcium

    2025

    Via American Journal of Preventive Cardiology

    Research

    A comparative analysis of cardiovascular disease mortality trends attributable to risk factors in the United States and globally from 1990 to 2019: an analysis of the Global Burden of Disease Study 2019

    2025

    Via American Journal of Preventive Cardiology

    Research

    The discovery of PCSK9 as a pivotal point in the prevention of cardiovascular disease

    2025

    Via American Journal of Preventive Cardiology

    Oct 16, 2025Journal Article

    Opportunistic Detection of Coronary Artery Calcium on Noncardiac Chest Computed Tomography: An Emerging Tool for Cardiovascular Disease Prevention: A Scientific Statement From the American Heart Association.

    ​
    ​
    ​+1

    Written by 3 Roon authors & 9 others

    Via The American Heart Association Journals
    Nov 18, 2025Journal Article

    2025 ACC/AHA/ASE/ASNC/SCCT/SCMR Advanced Training Statement on Advanced Cardiovascular Imaging: A Report of the ACC Competency Management Committee.

    ​
    ​

    Written by 2 Roon authors & 49 others

    Via The American Heart Association Journals

    Research

    Allocation of Semaglutide According to Coronary Artery Calcium and BMI: Applying the SELECT Trial to MESA

    2025

    Via JACC. Cardiovascular Imaging

    Research

    A Critical Appraisal of Lipid Management in the Post-Statin Era: Comparison on Guidelines, Therapeutic Targets, and Screening in a Case-Based Framework of Lipid Management

    2025

    Via JACC. Advances

    Research

    Advancing Preventive Cardiology: Innovations, Care Pathways, Global Challenges, and the Future of Cardiovascular Health Across the Life Course

    2025

    Via JACC. Advances

    Research

    ASPC president's page: Preventive cardiology in a Global context - Fostering collaboration and shared learning

    2025

    Via American Journal of Preventive Cardiology

    Research

    Association of Plasma Lipoprotein(a) With Major Adverse Cardiovascular Events in MASLD With or Without Advanced Liver Fibrosis

    2025

    Via Liver International

    Research

    Current Clinical Trials for Treating Elevated Lipoprotein(a)

    2025

    Via Current Cardiovascular Risk Reports

    Research

    Preventing Atherosclerosis in the 20's: Rethinking the Starting Line

    2025

    Via European Journal of Preventive Cardiology

    Aug 13, 2025Journal Article

    The Continuum of Prevention and Heart Failure in Cardiovascular Medicine: A Joint Scientific Statement from the Heart Failure Society of America and The American Society for Preventive Cardiology.

    ​
    ​
    ​+6

    Written by 8 Roon authors & 18 others

    Via Journal of Cardiac Failure

    Research

    Impact of a Meds-to-Beds PCSK9i Initiation Program on LDL-C in Patients Undergoing ASCVD Revascularization

    2025

    Via JACC. Advances

    Aug 22, 2025Clinical Trial, Phase III

    Effect of PCSK9 Inhibition With Alirocumab in Patients With Probable Familial Hypercholesterolemia or Type III Hyperlipoproteinemia: Results From the ODYSSEY OUTCOMES Trial.

    ​
    ​

    Written by 2 Roon authors & 13 others

    Via The American Heart Association Journals